Liposomal local therapy as treatment for sicca symptoms in patients with primary Sjögren's syndrome;Effekt liposomaler Lokaltherapie auf die Sicca-Symptomatik des primären Sjögren-Syndroms

HNO

Volumn 61, Issue 11, 2013, Pages 921-927

  Hofauer, B ^a   Bas, M ^a   Manour, N ^a   Knopf, A ^a  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

Autoimmune diseases; Keratoconjunctivitis sicca; Liposomes; Therapy; Xerostomia

Indexed keywords

EYE DROPS; LIPOSOME;

ADULT; AGED; ARTICLE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRY EYE; FEMALE; HUMAN; MALE; MIDDLE AGED; SJOEGREN SYNDROME; TREATMENT OUTCOME; VERY ELDERLY; XEROSTOMIA; YOUNG ADULT;

ADULT; AGED; AGED, 80 AND OVER; DRY EYE SYNDROMES; FEMALE; HUMANS; LIPOSOMES; MALE; MIDDLE AGED; OPHTHALMIC SOLUTIONS; SJOGREN'S SYNDROME; TREATMENT OUTCOME; XEROSTOMIA; YOUNG ADULT;

EID: 84888054085     PISSN: 00176192     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00106-013-2736-x     Document Type: Article

References (32)

1. Alobid I, Guilemany JM, Mullol J (2004) Nasal manifestations of systemic illnesses. Curr Allergy Asthma Rep 4(3):208-216
2. Alves MB, Motta AC, Messina WC, Migliari DA (2004) Saliva substitute in xerostomic patients with primary Sjögren's syndrome: a single-blind trial. Quintessence Int 35(5):392-396
3. Busato IM, Ignacio SA, Brancher JA et al (2012) Impact of clinical status and salivary conditions on xerostomia and oral health-related quality of life of adolescents with type 1 diabetes mellitus. Community Dent Oral Epidemiol 40(1):62-69
4. Carsons S (2001) A review and update of Sjogren's syndrome: manifestations, diagnosis, and treatment. Am J Manag Care 7(14 Suppl):S433-S443
5. Chisholm DM, Mason DK (1968) Labial salivary gland biopsy in Sjogren's disease. J Clin Pathol 21(5):1501-1508
6. Cohen J, Laing DG, Wilkes FJ (2012) Taste and smell function in pediatric blood and marrow transplant patients. Support Care Cancer 20:3019-3023
7. Fife RF, Chase WF, Dore RK et al (2002) Cevimeline for the treatment of xerostomia in patients with Sjögren syndrome: a randomized trial. Arch Intern Med 162(11):1293-1300
8. Fox RI, Dixon R, Guarrasi V, Krubel S (1996) Treatment of primary Sjögren's syndrome with hydroxychloroquine: a retrospective, open-label study. Lupus 5(Suppl 1):31-36
9. Fox R (2005) Sjögren's syndrome. Lancet 366:321-331
10. Furness S, Worthington HV, Bryan G et al (2011) Interventions for the management of dry mouth: topical therapies. Cochrane Database Syst Rev CD008934
11. Gilbard JP, Farris RL (1979) Tear osmolarity and ocular surface disease in keratoconjunctivitis sicca. Arch Ophthalmol 97:1642-1646
12. Johansson G, Andersson G, Edwardsson S et al (2001) Effects of mouthrinses with linseed extract Salinum® without/withchlorhexidine on oral conditions in patientswith Sjögren's syndrome. A double-blind crossoverinvestigation. Gerodontology 18(2):87-94
13. Kassan SS, Moutsopoulos HM (2004) Clinical manifestations and early diagnosis of Sjögren's syndrome. Ann Intern Med 164:1275-1284
14. Knopf A, Bas M, Chaker A et al (2011) Rheumatic disorders affecting the head and neck: underestimated diseases. Rheumatology (Oxford) 50(11):2029-2034
15. Kohler PF, Winter ME (1985) A quantitative test for xerostomia. The Saxon test, an oral equivalent of the Schirmer test. Arthritis Rheum 28(10):1128-1132
16. Lee S, Dausch S, Maierhofer G, Dausch D (2004) A new therapy concept with a liposome eye spray for the treatment of the "Dry Eye". Klin Monatsbl Augenheilkd 221:825-836
17. Liu B, Dion MR, Jurasic MM et al (2012) Xerostomia and salivary hypofunction in vulnerable elders: prevalence and etiology. Oral Surg Oral Med Oral Pathol Oral Radiol 114(1):52-60
18. Manthorpe R (2002) Sjögren's syndrome criteria. Ann Rheum Dis 61:482-484
19. Norés JM, Biacabe B, Bonfils P (2000) Olfactory disorders and general pathology. Analysis and review of the literature. Rev Med Interne 21(1):95-104
20. Ono M, Takamura E, Shinozaki K et al (2004) Therapeutic effect of cevimeline on dry eye in patients with Sjögren's syndrome: a randomized, double-blind clinical study. Am J Ophthalmol 138(1):6-17
21. Oxholm P, Manthorpe R, Prause JU, Horrobin D (1986) Patients with primary Sjögren's syndrome treated for two months with evening primrose oil. Scand J Rheumatol 15(2):103-108
22. Ramos-Casals M, Briton-Zerón P, Sisó-Almirall A, Bosch X (2012) Primary Sjögren syndrome. BMJ 344:e3821
23. Rhodus NL, Bereuter J (2000) Clinical evaluation of a commercially available oral moisturizer in relieving signs and symptoms of xerostomia in postirradiation head and neck cancer patients and patients with Sjögren's syndrome. J Otolaryngol 29(1):28-34
24. Shiboski SC, Shiboski CH, Criswell L et al (2012) American College of Rheumatology 286 classification criteria for Sjogren's syndrome: a data-driven, expert consensus approach in the Sjogren's International collaborative clinical alliance cohort. Arthritis Care Res (Hoboken) 64:475-487
25. Smidt D, Torpet LA, Nauntofte B et al (2011) Associations between oral and ocular dryness, labial and whole salivary flow rates, systemic diseases and medications in a sample of older people. Community Dent Oral Epidemiol 39(3):276-288
26. Soto-Rojas AE, Kraus A (2002) The oral side of Sjögren syndrome. Diagnosis and treatment. Arch Med Res 33(2):95-106
27. Steinfeld SD, Demols P, Salmon JS et al (2001) Infliximab in patients with primary Sjögren's syndrome: a pilotstudy. Arthritis Rheum 44:2371-2375
28. Steinfeld SD, Demols P, Appelboom T (2002) Infliximab in primary Sjögren's syndrome: one-yearfollowup. Arthritis Rheum 46:3301-3303
29. Vasconcelos AC, Soares MS, Almeida PC, Soares TC (2010) Comparative study of the concentration of salivary and blood glucose in type 2 diabetic patients. J Oral Sci 52(2):293-298
30. Vitali C, Bombardieri S, Jonsson R et al (2002) Classification criteria for Sjogren's syndrome: a revised version of the European criteria proposed by the American-European Consensus Group. Ann Rheum Dis 61(6):554-548
31. Vivino FB, Al-Hashimi I, Khan Z et al (1999) Pilocarpine tablets for the treatment of dry mouth and dry eye symptoms in patients with Sjögren syndrome: a randomized, placebo-controlled, fixed-dose, multicenter trial. P92-01 Study Group. Arch Intern Med 159(2):174-181
32. Wu AJ (2008) Optimizing dry mouth treatment for individuals with Sjögren's syndrome. Rheum Dis Clin North Am 34(4):1001-1010